Correlation Between DiaMedica Therapeutics and Phathom Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Phathom Pharmaceuticals, you can compare the effects of market volatilities on DiaMedica Therapeutics and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Phathom Pharmaceuticals.
Diversification Opportunities for DiaMedica Therapeutics and Phathom Pharmaceuticals
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DiaMedica and Phathom is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Phathom Pharmaceuticals go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Phathom Pharmaceuticals
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.89 times more return on investment than Phathom Pharmaceuticals. However, DiaMedica Therapeutics is 1.13 times less risky than Phathom Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Phathom Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 297.00 in DiaMedica Therapeutics on September 4, 2024 and sell it today you would earn a total of 237.00 from holding DiaMedica Therapeutics or generate 79.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Phathom Pharmaceuticals
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Phathom Pharmaceuticals |
DiaMedica Therapeutics and Phathom Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Phathom Pharmaceuticals
The main advantage of trading using opposite DiaMedica Therapeutics and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |